Info-base

Orvis Broncho Ambroxol solution for intravenous injection and inhalation 7.5 mg/ml 100 ml x1 Orvis

Instructions: Clinical and pharmacological group 16.014 (Drug that regulates the metabolism of calcium and phosphorus) Release form, composition and

Composition Spray for nasal use dosed 1 ml/1 dose active ingredients: xylometazoline hydrochloride 1/0.1

Composition Film-coated tablets 1 tablet. active ingredient: perindopril tosylate 2.5/5/10 mg (corresponds to

Composition Film-coated tablets 1 tablet. active substance: simvastatin 10 mg 20 mg

Instructions for use of PERINDOPRIL-LF Dual blockade of the RAAS is associated with an increased risk of developing arterial

Instructions for use of RAENOM® No effect on clinical outcomes in patients with symptomatic

Anesthesia (anesthetics, general anesthetics) are drugs that cause anesthesia